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Renal cortical cholesterol accumulation is an integral compo- Previous studies from this laboratory indicate that
nent of the systemic stress response. within 18 to 24 hours following the induction of ischemic
Background. Direct tubular injury (such as ischemia or myo- or toxic renal injury, dramatic increases in renal corticalhemoglobinuria) increases renal cortical cholesterol content.
cholesterol content result [1–3]. The following observa-This study explored whether systemic forms of stress (such as
tions characterize this ‘cholesterol overload’ state: (1) itheat shock or sepsis) can trigger renal cholesterol accumulation,
and if so, whether increased 3-hydroxy-3-methylglutaryl co- is expressed within the proximal tubular epithelium [1];
enzyme A (HMG-CoA) reductase (HMGCR) expression might (2) both free cholesterol (FC) and cholesteryl ester (CE)
be involved. pools are involved (20% to 50% and100% to 1000%Methods. Male CD-1 mice were subjected to glycerol-induced
increments, respectively) [2, 3]; (3) the degree of choles-myohemoglobinuria (MH), systemic heat shock (HS), or E.
coli sepsis. Free cholesterol (FC), cholesteryl esters (CE), and terol accumulation can reflect the severity of renal injury,
HMGCR (Western blot) levels were assessed 18 hours later. as assessed by blood urea nitrogen (BUN) concentrations
Statin effects on renal cholesterol levels and on the severity [3]; (4) post-renal injury cholesterol elevations are renal
of MH-acute renal failure (ARF) were also determined.
specific, that is, they are not part of a systemic, or general-Results. Sepsis and HS each induced dramatic FC and CE
ized, cholesterol overload state [3]; (5) post-injury choles-increments, comparable to those observed with myohemoglo-
binuria, and without inducing acute tubular necrosis (ATN). terol increases do not necessarily require systemic cytokine
Part of the cholesterol increments was localized within plasma release (such as, cultured proximal tubular cells main-
membrane (detergent resistant) microdomains (for example, tained in serum free medium up-regulate their cholesterolrafts/caveolae). HS and MH each increased renal HMGCR,
content in response to attack) [3]; and (6) while all of theas well as HS protein (HSP-72) expression. Oxidant stress (Fe)
pathobiologic consequences of post-renal injury choles-imposed on cultured proximal tubule (HK-2) cells also en-
hanced HMGCR content. Conversely, sepsis did not raise renal terol accumulation remain unknown, compelling evidence
HMGCR or HSP-72 levels. Statin therapy decreased the sever- indicates that it contributes to the “acquired cytoresis-
ity of MH-ARF and renal cholesterol content. However, this
tant” state (renal resistance to superimposed ischemicappeared to arise from a statin-mediated decrease in glycerol-
or toxic damage) [1–14]. Cholesterol’s protective role isinduced extrarenal tissue damage (myolysis/LDH release).
Conclusions. Cholesterol appears to be a renal ‘acute phase thought to be mediated, at least in part, by an increase in
reactant’ with tissue levels increasing with either systemic stress plasma membrane rigidity [1], which reduces membrane
(such as, heat shock, sepsis), or direct tissue damage (such as rupture during the evolution of necrotic cell death [15, 16].ATN). Increased HMGCR expression can contribute to this
The above observations raise a number of intriguingresult. Mechanisms other than HMGCR induction also can
questions. First, does the renal cholesterol accumulationmediate stress-induced cholesterol increments (for example,
in the case of sepsis), and statins can mitigate MH-ARF. How- evoked in response to acute renal failure (ARF) reflect
ever, systemic anti-inflammatory effects, rather than a primary a specific adaptation to direct tubular injury, or can it
renal action, appear more likely to be involved.
also be initiated by a more generalized, or systemic,
“stress” response? In other words, can systemic stress
(for example, as induced by heat shock or endotoxemia)
also evoke renal cholesterol accumulation in the absence
of overt tubular damage? If so, then altered cholesterolKey words: HMG-CoA reductase, heat shock, sepsis, myoglobinuria,
microdomains, inflammation. expression could have more broad based pathobiologic
relevance than previously recognized [1–3]. Second, al-Received for publication June 11, 2001
though it has generally been recognized that the vastand in revised form July 24, 2001
Accepted for publication July 26, 2001 majority (90%) of cholesterol is localized within the
plasma membrane [17, 18], it has become apparent that 2001 by the International Society of Nephrology
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within the plasma membrane, cholesterol-enriched micro- formed, blood was withdrawn from the inferior vena
cava for BUN analysis, and then the kidneys were re-domains exist [detergent resistant membranes (DRMs)
such as rafts and caveolae] [19–23]. Since these micro- sected. The renal cortices were dissected on an iced plate,
and used for one of the following assessments: (1) deter-domains concentrate a host of signaling molecules [such
as, endothelial nitric oxide synthesis (eNOS), Ras, plate- mination of free and esterified cholesterol content (FC
and CE, respectively; N  6 comparisons between postlet-derived growth factor (PDGF), protein kinase C
(PKC) ceramide, endothelial growth factor (EGF), Src, glycerol treated mice vs. control mice); (2) fractionation
of lipid extracts into either Triton 100 X insoluble (DRMceramide] [19–23], the issue of whether renal injury alters
cholesterol localization within them could be highly ger- fractions) or soluble fractions with subsequent FC and
CE analyses (N 13 glycerol treated mice vs. 13 normalmane. Third, the subcellular mechanisms by which renal
injury evokes tubular cholesterol accumulation remain mice for FC; N  7 glycerol treated mice vs. 7 normal
mice for CE); and (3) protein extraction for subsequentlargely undefined. In experiments conducted to date, it ap-
pears that cellular injury induces cholesterol accumula- HMGCR Western blot analysis (N  6 comparisons
between post-glycerol and control kidneys). Finally, fourtion via a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-
CoA) reductase (HMGCR) dependent pathway. This is cortical tissue samples were also probed for heat shock
protein 72 (HSP-72) by Western blot (see below). Thebased on observations that statin therapy blocks injury-
evoked cholesterol accumulation in cultured proximal methods used for each of these determinations are de-
scribed below.tubular (HK-2) cells [2, 3]. However, whether increased
HMGCR impacts renal cholesterol accumulation follow-
Glycerol induced ARF: Effects of HMGCR inhibitioning in vivo renal injury, and whether statin therapy might
attenuate this response, remain to be defined. The following experiment addressed whether inhibi-
tion of cholesterol synthesis via statin therapy alters glyc-Given the above considerations, the present study had
three specific aims: (1) to test whether renal cholesterol erol-induced renal cortical cholesterol accumulation and
the severity of the resultant ARF. To this end, 12 miceaccumulation develops in response to systemic, and not
just renal-specific, forms of stress; toward this goal, renal were divided into two experimental groups: Group 1
(N 6) was fed standard mouse chow to which 1.5 mg ofFC and CE levels were measured following in vivo heat
shock and Gram-negative sepsis; (2) to ascertain whether atorvastatin/g of food was added. Atorvastatin (“statin”)
was kindly provided by Pfizer Laboratories (Ann Arbor,stress-associated cholesterol accumulation is predomi-
nantly expressed within plasma membrane microdomains MI, USA). It was added to ground up chow, followed
by re-constituting the chow into pellets by adding small(DRMs); and (3) to test whether increased HMGCR
expression is a potential mediator of in vivo stress- amounts of water followed by drying. Group 2 (N  6)
received food subjected to the same procedure but with-induced renal cholesterol increments, HMGCR levels
following different forms of in vivo/in vitro stress were out statin addition. The mice were fed their respective
diets for 48 hours, during which time no differences ingauged by Western blot analysis. Additionally, the im-
pact of statin therapy on in vivo renal cholesterol accu- food intake or weight gain was observed (Results sec-
tion). The mice were then subjected to glycerol injection,mulation and injury responses were addressed.
as noted above, and returned to their original cages with
either the statin or control diet. Eighteen hours later,
METHODS
they were deeply anesthetized with pentobarbital, and
Glycerol model of myohemoglobinuric acute blood was obtained from the inferior vena cava for subse-
renal failure quent analysis. Following blood withdrawal, both kid-
neys were resected. One was transected longitudinally,Male CD 1 mice (weighing 25 to 35 g; Charles River
Laboratories, Wilmington, MA, USA) were used for all fixed in 10% formalin, and 4- histologic sections were
cut and stained with hematoxylin and eosin (H&E). Thein vivo experiments. They were maintained under normal
vivarium conditions with continuous free food and water other kidney was iced, the cortex was resected, and the
tissues analyzed for free and esterified cholesterol, asaccess. To induce rhabdomyolysis, they were briefly an-
esthetized with inhaled isoflurane, and then injected with previously described [2] and as noted below. The severity
of acute renal failure (ARF) was gauged by BUN con-hypertonic glycerol (50% solution; 8.5 mL/kg, adminis-
tered in equally divided doses into the upper hind limbs). centrations. In addition, plasma lactate dehydrogenase
(LDH) values were assessed, serving as a quantitativeThey were then allowed to recover from anesthesia
(within 30 seconds) and returned to their cages, again gauge of the severity of glycerol-induced myolysis/red
blood cell (RBC) hemolysis. [Note: creatinine phospho-with free food and water access. Approximately 18 hours
later, these mice, and an equal number of normal (con- kinase (CPK) levels were not measured, since they, un-
like LDH, rise in the presence of renal failure]. Histologictrol) mice, were deeply anesthetized with pentobarbital
(2 to 3 mg, IP), a midline abdominal incision was per- injury was graded semiquantitatively using a 1 to 4
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scale (minimal, mild, moderate, severe injury, respec- in which heat killed E. coli administered to rodents was
tively). This scoring system is based on extent of proximal employed [25, 26]. In brief, colonies of E. coli, isolated
tubular necrosis and heme protein cast formation, as from the urine of two patients with urosepsis, were ex-
previously described [24]. panded by culture in 1 liter of a bacterial culture medium
(“Terrific Medium”; Sigma). After three days, the cul-
Effect of statin therapy on normal mice ture was subdivided into twenty 50-mL aliquots; each
As a control for the above experiment, 10 mice were aliquot was centrifuged, and the pelleted organisms were
equally divided into a statin treatment group versus a washed with normal saline and re-pelleted. The bacteria
control group, as denoted above. After 48 hours, the in each tube were finally suspended in 10 mL of normal
mice were anesthetized with pentobarbital, and a blood saline (1  1010 organisms/mL) and stored at 20C.
sample was obtained for BUN and total cholesterol anal- Prior to use, a tube was thawed and placed in a boiling
ysis (the latter determined with a commercially available water bath for 20 minutes (rendering the organisms non-
kit from Sigma Chemicals, St. Louis, MO, USA). The viable, but leaving endotoxin intact [25, 26]) and then
left kidney was removed and processed for free and cooled. Thus, by using this preparation for injection, bac-
esterified cholesterol content, as described below. In ad-
teremia/endotoxemia can be induced without the atten-dition, HMGCR levels were probed by Western blot in
dant complications of an active infectious process [25, 26].both hepatic and right renal tissue samples. (Note: statins
Sepsis effects on cortical/DRM cholesterol expression,are known to up-regulate HMGCR in hepatic tissues via
HSP-72, and HMGCR levels. A total of 11 mice wereenzyme inhibition with a secondary increase in HMGCR
each injected with 1 mL of E. coli, administered as atranscription/translation).
single intraperitoneal (IP) injection. An equal number
Heat shock: Effects on renal cholesterol content and of mice, injected with 1 mL saline (the E. coli vehicle)
HMGCR content served as controls. Approximately 18 hours later, the
mice were anesthetized with pentobarbital, blood wasTen mice were deeply anesthetized with pentobarbital
obtained for BUN analysis, and then the kidneys wereas noted above. They were placed on surgical boards,
resected. One kidney from each mouse was used forand a small incision was made in the mid abdominal wall
renal cortical cholesterol analysis. The other kidney wasthrough which was passed a temperature probe. The
used either to prepare renal cortical protein extracts foranimals had their core body temperature raised to 40 to
41C by application of an external heating source. After Western blot analysis (for HMGCR/HSP-72 expression),
either 15 (N  4) or 30 (N  6) minutes of heat shock, or to determine % FC/CE distribution between DRM
the animals were allowed to regain normal temperature, versus non-DRM pools (see below).
the abdominal incision was sutured and the mice were
HMGCR expression in HK-2 cells followingreturned to their cages with free food and water access.
iron-mediated oxidative stressTen paired mice, subjected to the same protocol, but in
which body temperature was maintained at 36 to 37C The following experiment was conducted to help vali-
served as controls. Approximately 18 hours later, the date the finding that renal tubular stress can up-regulate
mice were re-anesthetized with pentobarbital, a plasma HMGCR protein expression. To this end, cultured proxi-
sample was obtained for BUN analysis, and then both mal tubular HK-2 cells were employed for two reasons:
kidneys were resected. One was used for renal cortical (1) it has previously been demonstrated that HMGCR
cholesterol/cholesterol ester determination, and the other is a mediator of HK-2 cell cholesterol accumulation in
was subjected to renal cortical protein extraction (see response to Fe-induced oxidative challenge (that is, mev-
below). The protein extracts were probed for HSP-72 astatin blocks that cholesterol accumulation [2]); and
[12], and HMGCR, as described below. The extent of (2) unlike the results obtained in renal cortex, resultsHSP-72 expression was semiqualitatively gauged as ei-
obtained with HK-2 cells can be directly attributed tother 1 (equal to the constitutive level of HSP-72 ob-
proximal tubular cell events. Eight T 75 Costar flasksserved in control tissues), or mild, moderate, or marked
(Cambridge, MA, USA) were seeded with HK-2 cells(2, 3, 4, respectively). These scores were correlated
and maintained in serum free medium as previously de-with FC and CE content. Finally, three mice were sub-
scribed [2]. After reaching near confluence, two flasksjected to 30 minutes of heat shock and 18 hours later
were exposed to 0, 2.5, 5.0, or 7.5 mol/L ferrous ammo-their kidneys were removed and processed for histologic
nium sulfate, complexed to the siderophore, hydroxy-analysis, as noted above.
quinoline (FeHQ [2]). After 18-hour exposures, the cells
Sepsis syndrome experiments: Effects on renal were detached with a rubber policeman and prepared
cortical cholesterol, HMGCR, and heat shock for Western blot analysis of HMGCR [27]. As a positive
protein expression control for this experiment, four additional flasks were
prepared and exposed for 72 hours to either control in-Escherichia coli preparation. To simulate a Gram-nega-
tive sepsis-endotoxemic state, a previously described model cubation conditions (N  2), or to 72 hours of 20 mol/L
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Fig. 1. Glycerol-induced myohemoglobinuria
increases renal cortical free cholesterol (FC)
and cholesteryl ester (CE) content. Values are
presented as nmoles cholesterol per mol
phospholipid phosphate (N  6 per group).
These values are representative of the total
cortical cholesterol pools that were then frac-
tionated into detergent-resistant membranes
(DRM) versus non-DRM pools (Fig. 2).
mevastatin (N  2). (Note: statins are expected to up- primary antibody (HSP-01; Oncogene Research Prod-
ucts; Cambridge, MA, USA), followed by a secondaryregulate HMGCR protein, due to the cholesterol synthe-
sis blockade). At the completion of the statin challenge, sheep anti-mouse HRP-linked IgG (Amersham-Pharma-
cia) was used. Visualization was conducted by enhancedthe cells were harvested and prepared for Western blot
analysis [27]. chemiluminescence (ECL kit; Amersham-Pharmacia),
according to the manufacturer’s instructions. Equivalent
Technical procedures protein loading/protein transfers were confirmed by In-
Free cholesterol and cholesterol ester determination. Tis- dia ink staining [12, 27]. Pre-stained sodium dodecyl sul-
sues were homogenized in 4 parts cold methanol, and fate-polyacrylamide gel electrophoresis (SDS-PAGE)
then extracted in chloroform/methanol [1, 2]. These ex- protein molecular weight standards were obtained from
tracts were analyzed for FC and CE by gas chromatogra- Bio-Rad (catalog # 161-0305; range 116 to 22 kD).
phy, as previously described in detail [2]. Values were
Calculations and statisticsexpressed as nmoles FC or CE per mole of sample
phospholipid phosphate [1, 2]. All values are presented as means 1 SEM. Data were
Preparation of DRM and non-DRM renal cortical frac- contrasted by the unpaired Student t test. If multiple
tions. Previously described methods were used to sepa- comparisons were made, the Bonferroni correction was
rate cortical tissue samples into soluble and insoluble applied. Histologic scores from the glycerol  statin ex-
fractions in cold Triton X 100 [28, 29]. The cold Triton periment were compared by the Wilcoxon rank sum test.
X-100 insoluble fractions were designated DRMs. The
successful separation of DRM from non-DRM pools us-
RESULTS
ing these methods was first confirmed in this laboratory
Glycerol induced ARFby demonstrating that the DRM fractions obtained from
normal kidney cortex were enriched in sphingomyelin, FC, CE, and DRM analyses. As shown in Figure 1,
renal cortical FC, and particularly CE, were strikinglyrelative to the non-DRM pool (DRM pool, 16 1% of
the total recovered phospholipid; vs. 101% in the non- elevated at 18 hours after the glycerol injection. The %
distribution of cholesterol into DRM versus non-DRMDRM pool; P 	 0.0025; N  6 comparisons [3]). Of
note, relative sphingomyelin enrichment is a marker of pools is presented in Figure 2. In control mice, 30  2%
of FC was recovered within DRMs. This relative amountDRMs [28–30].
Western blot analysis. Protein extracts were prepared increased to 39  2% following glycerol-induced myo-
hemoglobinuria (Fig. 2A). Similarly, DRMs were rela-for Western blot analysis and subjected to electrophore-
sis as previously described [12, 27]. Either 10% or 12% tively enriched in CEs, with the % rising from control
values of 12 0.3% to 16 1% in post-glycerol kidneysSDS pre cast gels (BioRad, Richmond, CA, USA) were
used for HMGCR and HSP-72, respectively. Samples (P 	 0.02).
As shown in Figure 2B, the BUN values for the glyc-were probed for HMGCR using a rabbit primary anti-
body (a gift from P.A. Edwards, Los Angeles, CA, USA) erol treated mice were elevated to 109  22 mg/dL (vs.
23  1 mg/dL for control mice). It has previously beenraised against purified rat HMGCR [31]. The secondary
antibody was donkey anti-rabbit, horseradish peroxidase reported that the absolute quantitative amounts of both
FC and CE within renal cortex strongly correlate with(HRP)-linked, IgG (Amersham-Pharmacia, Piscataway,
NJ, USA). For HSP-72 detection, a monoclonal mouse the severity of azotemia/ARF [3]. To determine whether
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Fig. 2. (A) Fractionation of total renal corti-
cal free and esterified cholesterol into DRM
versus non-DRM pools. The values represent
the % to which each fraction contributed to
the total recovered cholesterol content (the
sum of the absolute values in the DRM  the
non-DRM pools) in post-glycerol treated, and
normal (control) mice. As shown, there was
a modest and statistically significant increase
in both free cholesterol (FC) and cholesteryl
ester (CE) contributions to the DRM pool in
glycerol treated kidneys, compared to con-
trols. (B) Glycerol induced substantial azote-
mia. Both the % FC and % CE within the
DRM fractions for the glycerol treated ani-
mals directly correlated with the animals’
BUN concentrations. The r values for these
comparisons are: FC, 0.90; CE, 0.78.
Fig. 3. Effects of oral statin therapy of glyc-
erol (glyc) induced acute renal failure (ARF).
(A) A striking statin-induced reduction in the
extent of glycerol-induced azotemia, as re-
flected by BUN concentrations 18 hours post-
glycerol injection is apparent. Control BUN
values were obtained from normal mice. The
reduction in renal injury was also reflected by
a significant decrease in the extent of histo-
logic damage (see text). (B) The reduction is
azotemia was likely explained by a decrease
in glycerol-induced myolysis/hemolysis, as de-
noted by a striking decrease in plasma lactate
dehydrogenase (LDH) values.
a significant correlation also exists between the severity correlation between the semiquantitative histologic score
(1 to 4) with the prevailing BUN for each animal (r of ARF and the percent FC/CE localization within
DRMs, these percents were compared to the prevailing 0.93; not depicted). As previously described in detail,
the two principal histologic features of the glycerol ARFBUN for each animal. In both cases, significant correla-
tions were observed (BUN vs. % FC in DRM: r  0.90, model were: (1) extensive heme protein cast formation,
particularly in the outer and inner medulla; and (2) proxi-P 	 0.001; BUN vs. % CE in DRM: r  0.78, P 	 0.05).
mal tubular necrosis in cortical and outer medullary
Statin effects on glycerol-induced renal injury proximal tubular segments [24, 32].
LDH values. Terminal LDH concentrations (a markerAzotemia/histologic injury. Statin therapy dramatically
attenuated the severity of glycerol-induced ARF, de- of glycerol-induced myolysis/hemolysis) were strikingly
elevated with glycerol treatment, rising from normal val-creasing mean BUN values by 
50%, compared to the
glycerol control group (Fig. 3A). Not depicted is that a ues of 15 U/L to 1500 U/L (Fig. 3B). Statin therapy
dramatically reduced these glycerol triggered LDH ele-complete separation of BUN values existed for the two
groups (glycerol alone, all BUNs above 200 mg/dL vs. vations by 2/3 (P 	 0.01; Fig. 3B). The importance
of the statin-induced reduction in LDH values to theglycerol  statin, all BUNs 182 mg/dL). Renal histo-
logic analysis confirmed less renal injury with statin ther- observed protection of renal function was suggested by
a strong correlation between the observed post-glycerolapy (scores: glycerol, 3.7  0.4; glycerol  statin, 2.0 
0.6; P  0.05 by Wilcoxon rank sum test; if the scores LDH values and the resultant BUN elevation in each
animal (r  0.94; analyzing statin treated mice alone;were compared by the unpaired Student t test, the P
value was	0.015). The severity of azotemia (BUN eleva- Fig. 4). In the non-statin treated group, no significant
relationship between BUN and LDH values was ob-tion) appeared to be an accurate marker of the extent
of renal histologic injury. This was indicated by a strong served (r  0.09; Fig. 4). In total, the LDH data suggest
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Fig. 4. Relationship between BUN and LDH
values for each mouse post glycerol injection
with () or without () statin therapy. A
striking correlation (r  0.94) between these
two parameters was observed for the statin
treated mice. However, no such relationship
was observed for the glycerol mice that did
not receive statin therapy (r  0.09). Thus,
these results strongly suggest that statin-medi-
ated protection was due to a decrease in myo-
lysis/hemolysis.
Fig. 5. Effect of oral statin therapy on renal
cortical cholesterol accumulation in glycerol
(glyc)-induced myohemoglobinuric ARF. As
can be observed, both FC (A) and CE (B)
levels were modestly reduced by statin ther-
apy (presumably due to a decrease in renal
injury, not renal HMGCR inhibition, per se;
see Discussion). Control (or normal) renal
cortical FC/CE concentrations are presented
for comparison.
Table 1. Effects of three days of oral statin therapy of selectedthat the statin-induced protection was a result of a reduc-
parameters in normal mice
tion in glycerol-induced muscle necrosis/hemolysis with
Weighta secondary decrease in renal injury. (Note: statin ther- Renal Renal
Pre Post BUN PChol FC CEapy, in fact, did mitigate muscle injury was discerned
from direct visual evidence of decreased muscle swelling/ Controls 33.10.5 34.20.4 262 334 23714 4.00.6
Statin 34.90.6 35.70.9 281 244 24213 3.40.5edema at the sites of glycerol injection, compared to
P NS NS NS 	0.01 NS NSglycerol treatment without statin therapy.)
After 3 days of oral statin therapy, no change in body w/w gain or blood ureaRenal cortical cholesterol levels. A correlate of the
nitrogen (BUN) concentrations resulted. Statin therapy reduced plasma total
statin-mediated renal functional and histologic protec- cholesterol (PChol) by approximately 35%. However, no significant change in
renal cortical cholesterol content was observed. N 6 mice per group. Abbrevia-tion was a significant decrease in cortical FC and CE
tions are: FC, free cholesterol; CE, cholesteryl esters.
accumulation (Fig. 5) compared to the glycerol controls.
However, the CE values with statin therapy still re-
mained far above normal CE values (Fig. 5B). Importantly, statin therapy also did not reduce renal
FC/CE concentrations. Statin treatment did lower plasmaStatin effects on normal mouse cholesterol levels cholesterol levels by 33% (Table 1), confirming that
Given the dramatic effects of statin therapy on the the statin was pharmacologically active. As discussed
glycerol model of ARF, its effects on non-glycerol chal- later in this article (see Western blot analyses section),
lenged (control) mice were also assessed. As shown in the statin therapy failed to increase HMGCR expression
Table 1, statin therapy (as used in the glycerol experi- in renal cortex. Conversely, statin therapy did increase
HMGCR expression in liver.ment) did not alter body weight/weight gain, or BUN.
Zager and Johnson: Cholesterol and the stress response 2305
Fig. 6. Heat shock (HS) effects on renal cor-
tical FC and CE content. Both FC and CE
levels were significantly increased in response
to the heat shock protocols (N  10 animals
in control and heat shock groups).
Fig. 7. Correlation between the strength of
the heat shock response, as gauged by HSP-
72 expression, and the extent of FC (A) and
CE (B) accumulation. The extent of the heat
shock response was gauged on the basis of the
HSP-72 expression, as assessed semiquantita-
tively by Western blot (1, constitutive ex-
pression in normal cortex; 2, 3, 4, mild,
moderate, and marked increments, respec-
tively). As depicted, strong correlations be-
tween HSP-72 scores and FC/CE quantities
were observed.
Heat shock experiments lowing E. coli injections (ranging from 22 to 119 mg/dL).
For sake of comparison, five mice with BUN values ofAs depicted in Figure 6, heat shock caused significant
	35 mg/dL (NS vs. normal mice) and six mice with BUNincreases in renal cortical FC and CE content. The CE
values 
35 mg/dL were grouped for the sake of the FCincrement was particularly noteworthy. Western blot
and CE analyses. As shown in Figure 8, even the E. coli-analysis showed considerable variation in the extent of
challenged mice with minimal azotemia developed strik-HSP–72 expression (see Western blot analyses section).
ing elevations in renal cortical FC, and in particular, CEIn general, greater HSP-72 expression was observed with
content. As shown in Figure 9 A and B, the animals withthe 30-minute versus the 15-minute heat shock (41C)
greater degrees of azotemia (mean BUN, 114 3 mg/dL)protocol. The degree of HSP-72 elevation was graded
had comparable degrees of FC and CE elevations tosemiquantitatively, assigning scores of 1 to 4 (1,
those with lower BUN values. The lack of a relationshipconstitutive level of expression in normal kidneys; 2,
between degrees of azotemia in the sepsis model and3, 4, mild, moderate, marked HSP-72 elevations, re-
FC/CE elevations was reflected by r values of 0.26 andspectively). A comparison between the extent of HSP-72
0.25 (BUN vs. FC and CE, respectively).expression (score 1 to 4) and the degree of renal
Percent FC and CE distribution into DRM versus non-cortical FC and CE elevations revealed strongly correla-
DRM fractions. Total FC and total CE values for thetions (Fig. 7). Heat shock had no discernible effect on
tissues samples used for DRM analysis are presented inrenal function, as assessed by BUN concentrations mea-
Figure 9 A and B. The distribution of these cholesterolsured 18 hours later (heat shock 28  4 vs. control 25 
moieties between DRM versus non-DRM fractions are1 mg/dL). Heat shock also did not induce tubular necrosis
presented in Figure 9C. As shown, sepsis-induced renalor otherwise alter renal histology.
injury increased the relative amount of both FC and CE
Sepsis effects on renal cortical cholesterol expression within the DRM pools (compared to values observed in
control kidney cortical samples).Absolute FC and CE levels. There was considerable
variation in the extent of azotemia that developed fol- Renal histologic assessment. Five kidneys, obtained
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Fig. 8. Free and esterified cholesterol values
in the aftermath of E. coli sepsis in mice with
minimal azotemia (BUN 	35 mg/dL). Free
cholesterol (FC), and in particular cholesteryl
ester (CE), levels were substantially elevated
in these 6 mice, despite the fact that only mod-
est azotemia existed.
Fig. 9. Free and esterified cholesterol values in the aftermath of E. coli sepsis in mice with severe azotemia. The BUN values for this group of
11 mice were 114  3 mg/dL. As with the data in Fig. 8, highly significant FC (A) and CE (B) increments were observed. Despite the greater
azotemia in these mice vs. those used for the Fig. 8 data, comparable FC/CE accumulation was observed. This suggests that the CE/FC changes
were not a direct result of an azotemic state. As shown in (C ), the sepsis-induced cholesterol increases were associated with relative FC and CE
enrichment of the DRM fraction (consistent with the results obtained in the glycerol experiments).
from mice with BUNs of 
90 mg/dL, were selected for hepatic HMGCR is94,000 kD [27]). Its expression was
increased with both heat shock (row 1) and with thehistologic analysis. Three normal mouse kidneys, pro-
cessed simultaneously, served as controls. Despite severe glycerol ARF model (row 2, last 4 samples). However,
sepsis did not increase HMGCR expression (row 3). Ifazotemia, sepsis induced no evidence of tubular necrosis,
vasculopathy/thrombosis, or glomerular damage. Modest anything, a possible slight decrease in HMGCR levels
was observed.focal proximal tubular vacuolization was observed. How-
ever, this same vacuolization, albeit to a lesser degree, As expected, the heat shock protocol induced vari-
able degrees of HSP-72 protein increases (row 4). Glyc-also was observed in control kidneys (suggesting fixation
changes). These slides were subsequently examined by erol-induced myohemoglobinuria also induced a marked
HSP-72 response. In contrast, sepsis did not alter HSP-72an independent observer (Dr. Charles Alpers, University
of Washington, Seattle), and no additional alterations levels (data not depicted).
In HK-2 cells, HMGCR was identified as an approxi-were noted.
mate 40 kD band (Fig. 10, row 5), consistent with two pre-
Western blot analyses viously described HMGCR cleavage products (50 kD;
[27]). That this 40 kD band, in fact, did reflect HMGCRFigure 10 presents a representative composite of the
Western blots obtained during the course of these experi- was indicated by observations that mevastatin treatment
of HK-2 cells increased its expression in otherwise nor-ments. In renal cortex, HMGCR was recognized pre-
dominantly at a mass of 80 kD (for comparison, intact mal HK-2 cells (not shown). The FeHQ challenge also
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of whether specific forms of systemic stress, which typi-
cally do not evoke overt tubular damage (such as, hyper-
thermia/heat shock, sepsis/endotoxemia [25, 26, 33, 34]),
also might increase renal cortical cholesterol content.
Given cholesterol’s cytoprotective influences, were sep-
sis and/or hyperthermia to induce renal cholesterol accu-
mulation, protection against subsequent tubular injury,
and possibly ARF, could result.
To test whether systemic stress, indeed, does increase
renal cortical cholesterol expression, mice were subjected
to heat shock (40 to 41C  15 to 30 min), followed 18
hours later by renal cortical cholesterol assessments. We
found that heat shock induced notable FC and CE in-
crements, with the degree of the FC/CE accumulation
strongly correlating with HSP-72 expression (Fig. 7).
Thus, these data clearly establish, to our knowledge for
the first time, that renal cortical cholesterol accumula-
tion is a component of the heat shock response. A limited
number of previous studies have explored a potentialFig. 10. Western blot analysis of HMGCR, HSP-72 in renal cortex,
and HMGCR in HK-2 cells. Row 1: Variable degrees of up-regulation link between heat shock and the HMGCR/cholesterol
of HMGCR following in vivo heat shock (HS) are observed, compared synthetic pathway. However, inconsistent findings haveto amounts seen in sham treated control (C) mouse kidneys (80 kD).
resulted. For example, Shack et al noted that when cul-Row 2: The first two samples (left to right) denote that statin therapy
did not demonstrably increase HMGCR expression in renal cortex. In tured prostatic cancer cells were subjected to heat shock,
contrast, glycerol (glyc)-induced myohemoglobinuria caused a notable increased 14C acetate flux into cholesterol resulted (con-increase in renal cortical HMGCR levels, compared to control tissues.
sistent with increased HMGCR activity) [35]. Heat shockRow 3: HMGCR expression in cortical tissues samples obtained from
control mice and from mice subjected to 18 hours of sepsis syndrome. also can stimulate HMGCR activity in plants based on
No increase, or perhaps a slight decrease, in HMGCR in the sepsis sam- findings of increased leaf production of isoprene, anples is observed. Row 4: HSP-72 expression following in vivo heat shock.
HMGCR product [36, 37]. However, heat shock has beenVariable degrees of HSP-72 increments were observed, compared to
control tissues. Overall, HSP-72 semiquantitative scores strongly corre- reported to suppress cholesterol synthetic pathways in
lated with renal cortical FC/CE expression (see Fig. 7). Row 5: HMGCR cultured hepatocytes [38, 39]. Clearly, our data are moreexpression in HK-2 cells. Control (C) denoted no Fe challenge; 5 Fe is
consistent with the first two sets of observations, and5 mol/L ferrous ammonium sulfate complexed with hydroxyquinoline
(FeHQ) challenge, and 7.5 Fe is 7.5 mol/L FeHQ challenge. A strong offer two additional new insights. First, we believe that
dose-dependent relationship between the amount of added Fe and the the present study is the first to demonstrate that heatamount of HMGCR expression is apparent.
shock increases absolute cholesterol content, and not
simply HMGCR activity. (Of note, increased HMGCR
activity and cholesterol accumulation are by no means
increased HK-2 cell HMGCR in a dose-dependent fash- synonymous [40].) Second, our results are the first to
ion (Fig. 10, row 5). While the 2.5 mol/L Fe dose (not document that heat shock increases in vivo (renal) cho-
shown) did not increase HMGCR over control values lesterol levels. The latter observation raises a substantial
(two left hand samples), both the 5 and 7.5 mol/L Fe interpretative quandary, since HSPs are widely viewed
doses caused dose-dependent HMGCR increments. as being renal cytoprotective. These injury-modifying ef-
Oral statin therapy increased HMGCR expression in fects now will need to be interpreted in light of an accom-
panying increase in cytoprotective cholesterol content.liver (data not shown). However, it failed to do so in
To further explore the impact of systemic stress onkidney (as depicted by the first two samples of row 2).
renal cortical cholesterol accumulation, sepsis syndrome
was simulated by heat killed E. coli injection. This model
DISCUSSION [25, 26] has previously been noted to cause a pre-renal,
It has previously been determined that diverse forms or hemodynamic, form of ARF (recapitulating the renal
of renal injury (ischemic, toxic, immunologic, and ob- effects of endotoxemia) [34]. We now demonstrate that
structive [1–3]) can each evoke profound renal cortical a correlate of this septic state is a marked increase in
cholesterol and cholesteryl ester increments. The highly renal cortical cholesterol/cholesterol ester content. To
divergent natures of these insults suggest that this choles- our knowledge, this is the first demonstration that sepsis
terol accumulation might be part of a generic “stress syndrome can effect such a change. Three points are
response,” rather than being a specific adaptation to particularly noteworthy in this regard. First, the choles-
terol increments cannot simply be ascribed to potentialtubular injury, per se. This raises the intriguing question
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hyperthermic heat shock, since hypothermia is a concom- that injury-associated cholesterol increments within HK-2
cells can be completely blocked by statin therapy [1].itant of this model [25]. This undoubtedly explains why
no HSP-72 induction resulted. Second, the E. coli-initi- While this proves that HMGCR is critical for inducing
cholesterol accumulation in HK-2 cells, whether these inated cholesterol accumulation almost certainly stemmed
from endotoxemia, or a resultant cytokine storm, rather vitro results have in vivo relevance, and whether HMGCR
plays its role via increased enzyme expression, or simplythan from ARF, per se. This is based on observations that
even those mice that manifested virtually no azotemic via increased HMGCR enzyme activity (that is, post-
translational up-regulation [42, 43]) remain unknown.response to E. coli injection developed substantial cho-
lesterol increments. Finally, to our knowledge, this is the To gain initial insights into this issue, HMGCR protein
levels were assessed following both in vivo and in vitrofirst documentation that renal cholesterol accumulation
can result from a non-structural, or hemodynamic, form tissue injury via Western blot analysis. The results of those
studies provide the following insights: First, increasedof ARF. Indeed, it is intriguing to postulate that if a pre-
renal state can initiate renal cholesterol accumulation, a HMGCR protein expression, indeed, can be a concomit-
ant of renal stress. This is based on observations that Fe-transition to ischemic acute tubular necrosis might not
result. The absence of any tubular necrosis in the current mediated oxidative stress induced either in vivo (glycerol
induced myohemoglobinuria) or in vitro (FeHQ-medi-sepsis model is at least consistent with this possibility.
Having defined that cholesterol accumulation can be ated HK-2 cell injury) produced an increase in HMGCR
protein content. Second, increased HMGCR expressiona renal adaptational response to systemic stress, the next
goal of this study was to ascertain whether the cholesterol is not simply confined to Fe-mediated oxidative injury,
given that heat shock also evoked renal cortical HMGCRincrements primarily traffic to DRM microdomains, or
whether a more generalized distribution results. Based protein increments. Third, one cannot simply conclude
that all post-stress cholesterol accumulation occurs viaon our previous hypothesis that cholesterol confers cyto-
protection by decreasing plasma membrane fluidity and a single mechanistic pathway. This principle is under-
scored by the fact that E. coli sepsis triggered markedby stabilizing mitochondrial function [1, 41], a priori, one
might assume that the cholesterol accumulation is not in vivo cholesterol accumulation, but in the absence of
any discernible increase in HMGCR content. Althoughsimply confined to plasma membrane microdomains.
However, to directly address this question, FC and CE the mechanism(s) by which sepsis triggers renal cortical
cholesterol accumulation remains unknown at this time,distribution between DRM versus non-DRM fractions
was ascertained. The sepsis and glycerol ARF models, no shortage of possibilities exists. These include: (i) in-
creased HMGCR activity without increased enzyme lev-rather than heat shock, were chosen for these assess-
ments because they induced more consistent cholesterol els (for example, decreased phosphorylation or proteo-
lytic enzyme inactivation [42]); (ii) increased cellularincrements. In both models showed FC and CE enrich-
ment of the DRM pools, but the extent was quite modest, cholesterol uptake (such as, via the LDL or SR-B1 re-
ceptors [40, 44, 45]); (iii) decreased cellular cholesterolrising only 5 to 10% over basal values. Therefore, in
light of the marked total FC/CE increments within whole efflux; or (iv) various combinations of the above. The
critical point appears to be as follows: Whereas diverserenal cortex, it is apparent that the bulk of the cholesterol
accumulation achieved a non-DRM location. Based on insults can increase renal cholesterol accumulation, the
underlying mechanism(s) are likely to vary, and in athese observations, one would assume that the excess
cholesterol likely trafficked to the non-DRM plasma disease specific fashion. Indeed, given the great complex-
ity of cholesterol homeostatic mechanisms, even withinmembrane compartment, which normally contains the
bulk of cellular cholesterol content [18, 19]. Supporting a single disease state multiple mechanisms are likely to
be involved.this assumption are our previous observations that meth-
ylcyclodextrin, a plasma membrane-active cholesterol A seemingly ideal way to ascertain the mechanistic
role of HMGCR in renal cholesterol accumulation would“stripping agent,” normalizes cholesterol levels in cyto-
resistant renal tubules [1]. Whether non-plasma mem- be to test whether statin therapy abrogates this response.
Thus, the impact of oral atorvastatin on both normalbrane fractions become cholesterol enriched in the after-
math of renal stress (such as, lysosomal, mitochondrial, mice and on mice subjected to the glycerol ARF model
(with documented HMGCR increments) was assessed.and ER compartments) remains unknown. However,
given the fact that mitochondria, as well as plasma mem- The results of these studies were surprising in at least
three respects.branes, directly contribute to renal cytoresistance sup-
port this possibility [41]. First, while there is no doubt that the statin therapy
was biologically active (it decreased plasma cholesterolPrevious studies performed in cultured proximal tubu-
lar (HK-2) cells indicate that HMGCR-mediated choles- levels by 35%), it failed to lower the renal cortical
cholesterol content in normal mice. Two possible expla-terol synthesis is largely responsible for injury-induced
cholesterol accumulation. This is based on observations nations for this negative result are as follows: (i) statins
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undergo first pass/enterohepatic clearance and are highly systemic stress response, and not simply a specific adap-
protein bound; hence, they may have minimal renal bio- tation to direct ischemic, or nephrotoxic renal disease.
availability; and (ii) even if some direct renal bioactivity (2) The mechanisms by which renal stress evokes cho-
does exist, a decrease in renal cholesterol synthesis could lesterol accumulation may stem, at least in part, from
simply be offset by increased cholesterol uptake from increased HMGCR protein expression, which can rise
circulating pools (such as, via the LDL or SR-B1 recep- in a heat shock protein-like response. However, this is
tors). In either event, the finding that statin therapy did not the only pathway by which stress can evoke renal
not decrease cholesterol content in normal kidney sug- cholesterol accumulation, as denoted by the fact that
gests that it may be an impractical biologic probe for E. coli sepsis caused striking renal cholesterol incre-
assessing renal HMGCR activity. ments in the absence of an HMGCR (or, for that mat-
Second, despite the fact that atorvastatin did not de- ter, an HSP-72) response. (3) Stress induces relative cho-
crease cholesterol levels in normal kidneys, it markedly lesterol enrichment of plasma membrane microdomains
decreased them in the setting of glycerol-induced ARF. (DRMs). However, these DRM increments cannot ac-
This seems paradoxical in light of the points made just count for the bulk of the cholesterol accumulation, thereby
above. However, a ready explanation does exist: we have indicating that more generalized plasma membrane/cel-
previously reported that renal cholesterol accumulation lular cholesterol distribution must exist. (4) Whereas
following myohemoglobinuria is directly and strongly re- statins might appear to be ideal biological probes for
lated (r 0.90) to the extent of renal damage [3]. Since assessing the role of HMGCR in renal disease, two points
statin therapy markedly attenuated glycerol-induced renal must be considered: (i) statins may have minimal ability
injury (50% reductions in BUN), a comparable reduc- to directly affect renal cholesterol content (due either
tion in renal cholesterol levels would be expected. to limited bioavailability or to offsetting cholesterol ho-
Third, as noted above, atorvastatin surprisingly re- meostatic mechanisms); and (ii) statins can directly in-
duced the severity of glycerol-induced ARF. This was fluence extrarenal inflammatory pathways that can sec-
due almost certainly to its ability to decrease glycerol- ondarily alter the evolution of renal damage. Thus,
mediated extrarenal/muscle tissue damage (as denoted mechanistic conclusions based on results obtained with
by a 2/3 reduction in plasma LDH levels and physical statin therapy need to be interpreted with caution.
evidence of less muscle edema). This would be expected
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